Allergan Acquires Dry Eye Startup Biz

Source: Zacks

Jul 07, 2015

Allergan has agreed to acquire development-stage medical device company, Oculeve, which is focused on developing novel dry eye disease treatments.

Allergan will pay $125 million upfront, with potential milestone payments related to Oculeve's lead development program OD-01.

Allergan expects to file for FDA approval in 2016 for OD-01, a non-invasive nasal neurostimulation device that increases tear production in patients. OD-01 involves small devices inserted into the mucous membrane of the nasal cavity and under the skin below the eyebrow.

Read the Zacks article

Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.

Comments

No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments